These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11327197)

  • 1. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
    Aminimanizani A; Beringer P; Jelliffe R
    Clin Pharmacokinet; 2001; 40(3):169-87. PubMed ID: 11327197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of fluoroquinolones.
    Turnidge J
    Drugs; 1999; 58 Suppl 2():29-36. PubMed ID: 10553702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of fluoroquinolones.
    Rodvold KA; Neuhauser M
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):233S-252S. PubMed ID: 11642690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of sparfloxacin.
    Shimada J; Nogita T; Ishibashi Y
    Clin Pharmacokinet; 1993 Nov; 25(5):358-69. PubMed ID: 8287631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gatifloxacin, an advanced 8-methoxy fluoroquinolone.
    Fish DN; North DS
    Pharmacotherapy; 2001 Jan; 21(1):35-59. PubMed ID: 11191737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones.
    Stein GE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S19-24. PubMed ID: 8953102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fluoroquinolones in tuberculosis today.
    Berning SE
    Drugs; 2001; 61(1):9-18. PubMed ID: 11217874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.
    Wispelwey B
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S127-35. PubMed ID: 15942879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Coyle EA; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1654-9. PubMed ID: 11353608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of protein binding of quinolones.
    Bergogne-Bérézin E
    Clin Pharmacokinet; 2002; 41(10):741-50. PubMed ID: 12162760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
    Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of fluoroquinolones.
    Lode H; Borner K; Koeppe P
    Clin Infect Dis; 1998 Jul; 27(1):33-9. PubMed ID: 9675446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of gatifloxacin, a new fluoroquinolone.
    Grasela DM
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S51-8. PubMed ID: 10984329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit.
    Fish DN
    Int J Antimicrob Agents; 2007 Jun; 29(6):715-23. PubMed ID: 17433631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.
    Pickerill KE; Paladino JA; Schentag JJ
    Pharmacotherapy; 2000 Apr; 20(4):417-28. PubMed ID: 10772373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity and pharmacodynamics of new quinolones.
    Dalhoff A; Schmitz FJ
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):203-21. PubMed ID: 12687416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.